Compared with the conventional prognostic indexes such as age, sex, TNM stage, and BMI, the risk score created by the CCR6 gene expression can better predict the survival of patients, which also confirms that the gene-based expression signal can accurately predict the prognosis of patients with melanoma. This evidence concerns the gene CCR6 and melanoma.